Today: 19 July 2026
Archer Aviation Stock Price Today: ACHR Rises Despite Fresh Insider Sale Filings
17 March 2026
1 min read

Archer Aviation Stock Price Today: ACHR Rises Despite Fresh Insider Sale Filings

NEW YORK, March 17, 2026, 5:12 PM EDT

Archer Aviation Inc. ended Tuesday up roughly 2.8% at $6.29, shrugging off new SEC disclosures of minor insider sales for tax purposes. Still, the stock hasn’t climbed back to its March 2 close of $7.52, set right before Archer reported full-year earnings and warned of a deeper Q1 loss.

This matters because Archer is still burning through cash, with shares reacting more to certification milestones, launch schedules, and dilution fears than any real top-line growth. As of the end of 2025, Archer had about $2.0 billion in liquidity on its books, but the company reported a net loss of $618.2 million and projected an adjusted EBITDA loss of $160 million to $180 million for the first quarter.

Bulls are watching the U.S. regulatory picture closely. Last week, Archer announced its Florida, New York, and Texas partners were tapped for the government’s eVTOL Integration Pilot Program—those battery-powered “vertical takeoff” aircraft that fly like planes. The FAA and Department of Transportation indicated that chosen projects might start flying by summer 2026. Goldstein called it “the clearest sign yet” that U.S. air taxi commercialization has become a government priority. Archer Aviation

On March 2, Archer reported that the FAA signed off on 100% of Midnight’s Means of Compliance — the checklist of tests and procedures required to validate the aircraft’s airworthiness. “Everything we’ve built” is coming together, CEO Goldstein said. The company stuck to its plan for launching passenger flights in 2026. Archer Aviation

Competitors aren’t standing still. Just last week, Joby Aviation announced it’s flying its first production-model aircraft, now headed for certification tests with federal regulators. Back on March 9, Reuters reported that Beta Technologies, along with Joby and Archer, each secured several slots in the pilot program.

Monday’s Form 4s flagged smaller-scale insider sales: Interim CFO Priya Gupta unloaded 7,263 shares, and Chief Legal & Strategy Officer Eric Lentell sold 8,059 shares, both on March 13. According to the filings, the moves were automatic—triggered by company policy to cover tax obligations on performance awards that had vested.

The core challenge remains: Archer must prove its aircraft can do more than collect approvals and line up partners. Back in January, Needham’s Chris Pierce argued that real momentum would come only if Midnight flies across its full range. Then, in a March 5 8-K, Archer disclosed plans to pay vendors with up to $8 million in stock and register 5.3 million shares for resale by current holders.

As of March 12, nine analysts tracked by Reuters are following Archer, most putting an Outperform rating on the stock. The shares got a boost Tuesday, giving Archer a bit of breathing room—not a full reprieve. With flights, infrastructure, and certification milestones still ahead, the stock’s moves will likely continue to follow the news cycle.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • Molina Healthcare: Market Sentiment Misses the Mark
    July 19, 2026, 6:19 AM EDT. The market's reading of Molina Healthcare's valuation appears mistaken, opening a window for investors. An independent finance expert, experienced in macroeconomic analysis, technical patterns, and momentum-driven trading, makes the case that shares are currently undervalued. The analyst's method prioritises capital protection and a favourable risk-reward profile, blending Growth At A Reasonable Price (GARP) with momentum strategies for a balanced investment framework. The article highlights Molina Healthcare's prospects with actionable, data-backed observations in a turbulent market, encouraging investors to reassess the cautious outlook now prevailing.
Gold Price Today Falls as Dollar Rises, but Fed and Oil Shock Keep Bullion in Play
Previous Story

Gold Price Today Falls as Dollar Rises, but Fed and Oil Shock Keep Bullion in Play

Gold Price Today: Bullion Steadies Near $4,400 After Monday’s Violent Selloff
Next Story

Gold Price Today: Bullion Steadies Near $4,400 After Monday’s Violent Selloff

Go toTop